# Viking Therapeutics

Viking Therapeutics is an Asset Manager based in San Diego, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** San Diego, United States
- **Region:** North America
- **Address:** San Diego, CA, United States
- **Founded:** 2012
- **Assets under management:** Undisclosed
- **Website:** vikingtherapeutics.com
- **LinkedIn:** https://www.linkedin.com/company/viking-therapeutics

## Regulatory record

- **Reports private funds:** No

## About

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders.

## Sectors

- Digital Health
- Healthcare Services

## People

- Brian Lian — CEO

## Questions

### Who runs key development and investment decisions at Viking Therapeutics?

Brian Lian, Ph.D., has served as President and CEO since the company’s founding in 2012. The board of directors and executive leadership team make capital-allocation and pipeline-prioritization decisions within the standard public-company governance framework.

### How is Viking Therapeutics’ obesity program positioned against Eli Lilly and Novo Nordisk?

Viking’s lead candidate, VK2735, is a dual GLP-1/GIP receptor agonist available in both subcutaneous and oral formulations. The Phase 3 program for the oral version, initiated in January 2025, aims to demonstrate competitive weight-loss efficacy and tolerability in the same incretin market that Lilly’s tirzepatide and Novo’s semaglutide now dominate.

### What therapeutic areas does Viking Therapeutics avoid?

Viking has not disclosed any pipeline activity outside metabolic and endocrine disorders. Its public pipeline is concentrated on NASH, X-ALD, and obesity, and the company has not announced oncology, neurology, or anti-inflammatory programs.

### How does Viking Therapeutics fund its operations?

The company finances its operations primarily through follow-on public equity offerings and at-the-market (ATM) programs. It does not operate an in-house discretionary investment portfolio or deploy capital as a multi-strategy asset manager.

## Related profiles

- [Bath & Body Works](https://altss.com/profile/bath-and-body-works-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/viking-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology